Event Details
2019 Cardiology Update Symposium
About This Event
- Event Type:Event
- Max Capacity:0
Brought to you by St. Joseph and St. Mary’s Medical Centers and Kansas City Cardiology
The 2019 Cardiology Update is a one-day symposium designed for physicians,
nurses, advanced practice providers, and other health professionals in
acute and ambulatory care settings.
Eight national and local experts will give talks on new treatment guidelines,
procedures, and evidence-based practices in cardiovascular medicine.
Friday, April 26, 2019
Agenda
7:15 a.m. Registration
7:55 a.m. Welcome and Introduction, David Blick, M.D., F.A.C.C.
8 a.m.
Update on TAVR, Jeffrey Sparling, M.D, F.A.C.C., F.S.C.A.I.
8:50 a.m.
Anticoagulation in Non-Valvular Atrial Fibrillation, Hiren Shah, M.D.
9:40 a.m. Break
9:55 a.m.
Reversal of Oral Anticoagulation Therapy, Paul Dobesh, Pharm. D., F.C.C.P., B.C.P.S., B.C.C.P.
10:45 a.m.To Play or Not to Play- Athletes and Heart Disease, Anthony Magalski, M.D., F.A.C.C., F.A.H.A., F.A.S.E., F.H.F.S.A.
11:35 a.m. Lunch
12:15 p.m.
Smoking Cessation in the Setting of Cardiovascular Disease, Edward Ellerbeck, M.D., M.P.H.
1:05 p.m.Cannabinoid Cardiovascular Concerns, Michael Barton, Pharm. D., B.C.P.S., B.C.G.P.
1:55 p.m. Break
2:10 p.m.
Minimizing Cancer Treatment Related Cardiovascular Toxicities, Charles Porter, M.D.
3:00 p.m.
Borderline Elevated Troponin- MI or Not? David Blick, M.D., F.A.C.C.
3:50 p.m. Evaluation and Adjournment
Educational Objectives
• Discuss the latest indications and success with Transcatheter Aortic
Valve Replacement
• Review options available for patients requiring anticoagulation
for non-valvular atrial fibrillation
• Explain Pharmacological Reversal Agents for Anticoagulated Patients
• Recognize the prevalence and potential causes of sudden cardiac
death in young athletes
• Discuss the challenges surrounding pre-participation cardiac screening
of athletes
• Understand how to address smoking cessation in the setting of CV
disease with a particular emphasis on the efficacy and safety of cessation
pharmacotherapy
• Identify strategies for making systematic improvements in the delivery
of cessation treatment to patients with CV disease
• Discuss potential clinical concerns with cannabis use and cardiac effects
• Explain the treatment of Cardiovascular Disease in Patients with Cancer
• Discuss Elevated Troponin Levels and the Relationship to Acute MI
Sandra Dorrell, 816-525-1600 ext. 231
Registration- Price: $80.00
- Registration Instructions: Please click and download the above registration form or call 816-525-1600 ext. 231 for more information or register via phone.